How The Cannabis Industry Can Solve The Schedule-I Drug Research Barrier Problem

Research is forbidden on Schedule I drugs in the U.S. — here's how marijuana can get around that rule.

The post How The Cannabis Industry Can Solve The Schedule-I Drug Research Barrier Problem appeared first on The Fresh Toast.

Due to this shift in paradigm, the DEA was forced to shift their stance on certain drugs. First with cannabis and now with psychedelics. The public had to twist the arm of the government in order to have them say, “Sure we’re thinking about making it easier to research…just give us time!”